Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2018 5
2020 6
2021 5
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Investigating genetic diversity in admixed populations from Ecuador.
Flores-Espinoza R, Paz-Cruz E, Ruiz-Pozo VA, Lopez-Carrera M, Cabrera-Andrade A, Gusmão L, Burgos G. Flores-Espinoza R, et al. Among authors: cabrera andrade a. Am J Phys Anthropol. 2021 Sep;176(1):109-119. doi: 10.1002/ajpa.24341. Epub 2021 Jun 25. Am J Phys Anthropol. 2021. PMID: 34169504
A Multi-Objective Approach for Drug Repurposing in Preeclampsia.
Tejera E, Pérez-Castillo Y, Chamorro A, Cabrera-Andrade A, Sanchez ME. Tejera E, et al. Among authors: cabrera andrade a. Molecules. 2021 Feb 3;26(4):777. doi: 10.3390/molecules26040777. Molecules. 2021. PMID: 33546161 Free PMC article.
Population-Specific Distribution of TPMT Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine.
Gallardo-Cóndor J, Naranjo P, Atarihuana S, Coello D, Guevara-Ramírez P, Flores-Espinoza R, Burgos G, López-Cortés A, Cabrera-Andrade A. Gallardo-Cóndor J, et al. Among authors: cabrera andrade a. Ther Clin Risk Manag. 2023 Nov 29;19:1005-1018. doi: 10.2147/TCRM.S432856. eCollection 2023. Ther Clin Risk Manag. 2023. PMID: 38050617 Free PMC article.
Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.
López-Cortés A, Guerrero S, Ortiz-Prado E, Yumiceba V, Vera-Guapi A, León Cáceres Á, Simbaña-Rivera K, Gómez-Jaramillo AM, Echeverría-Garcés G, García-Cárdenas JM, Guevara-Ramírez P, Cabrera-Andrade A, Puig San Andrés L, Cevallos-Robalino D, Bautista J, Armendáriz-Castillo I, Pérez-Villa A, Abad-Sojos A, Ramos-Medina MJ, León-Sosa A, Abarca E, Pérez-Meza ÁA, Nieto-Jaramillo K, Jácome AV, Morillo A, Arias-Erazo F, Fuenmayor-González L, Quiñones LA, Kyriakidis NC. López-Cortés A, et al. Among authors: cabrera andrade a. Front Pharmacol. 2022 Mar 29;13:833174. doi: 10.3389/fphar.2022.833174. eCollection 2022. Front Pharmacol. 2022. PMID: 35422702 Free PMC article.
24 results